chlormadinone acetate has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuoka, K; Hayashi, T; Inoue, S; Kadonishi, Y; Kajiwara, M; Kobayashi, K; Matsubara, A; Mita, K; Nagamatsu, H; Shigeta, M; Tacho, T; Teishima, J | 1 |
| Hagiwara, M; Hayakawa, N; Ito, Y; Maeda, T; Matsumoto, K; Nagata, H; Nakamura, S; Ninomiya, A; Tanaka, N | 1 |
1 review(s) available for chlormadinone acetate and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Third-line hormonal therapy to treat prostate cancer relapse after initial and second-line hormonal therapy: report of 52 cases and literature review.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Cohort Studies; Flutamide; Gonadotropin-Releasing Hormone; Humans; Kallikreins; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Tosyl Compounds; Treatment Outcome | 2014 |
1 other study(ies) available for chlormadinone acetate and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Chlormadinone Acetate; Flutamide; Humans; Male; Middle Aged; Nitriles; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Rate; Tosyl Compounds | 2020 |